Erwin Sablon
Chief Tech/Sci/R&D Officer bij Biocartis SA
Profiel
Erwin Sablon is currently the Head of Applied Research & Development at Biocartis SA since 2013.
Prior to this, he was the Director of Project Management at Ablynx NV from 2008 to 2010.
He also served as the Head of Research & Development at Fujirebio Europe NV.
From 2010 to 2020, Dr. Sablon held the position of Head of Research & Development and Alliance Management at Biocartis Group NV.
Dr. Sablon holds a doctorate degree from Ghent University and an MBA from Vlerick Leuven Gent Management School.
Actieve functies van Erwin Sablon
| Bedrijven | Functie | Begin |
|---|---|---|
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Chief Tech/Sci/R&D Officer | 19-11-2013 |
Eerdere bekende functies van Erwin Sablon
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOCARTIS GROUP NV | Chief Tech/Sci/R&D Officer | - |
| ABLYNX | Corporate Officer/Principal | 01-01-2010 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Erwin Sablon
| Ghent University | Doctorate Degree |
| Vlerick Leuven Gent Management School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOCARTIS GROUP NV | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
